Activities per year
Activities
- 1 - 50 out of 2,169 results
Search results
-
SAHMRI Precision Cancer Medicine Theme Seminar Series
Eadie, L. (Participant)
10 Apr 2024Activity: Other
-
Australian and New Zealand Children’s Haematology/Oncology Group (ANZCHOG) Scientific Meeting
Eadie, L. (Participant)
1 Aug 2024 → 3 Aug 2024Activity: Other
-
Cancer Institute New South Wales Translational Cancer Research Centre (External organisation)
Skelton, K. (Member)
1 Apr 2024Activity: Membership › Membership of committee
-
New Directions in Leukaemia Research (NDLR)
Eadie, L. (Participant)
4 Mar 2024 → 6 Mar 2024Activity: Other
-
New Directions in Leukaemia Research (NDLR)
Eadie, L. (Participant)
4 Mar 2024 → 6 Mar 2024Activity: Other
-
Trans-Tasman Radiation Oncology Group - TROG Cancer Research (External organisation)
Le, H. (Chair)
2024 → …Activity: Membership › Membership of committee
-
New Directions in Leukaemia Research (NDLR)
Eadie, L. (Participant)
4 Mar 2024 → 6 Mar 2024Activity: Other
-
26th Annual ESH-iCMLF International Conference on CML – Biology and Therapy
Eadie, L. (Participant)
27 Sept 2024 → 29 Sept 2024Activity: Other
-
New Directions in Leukaemia Research (Event)
Eadie, L. (Chair)
Aug 2024 → …Activity: Membership › Membership of committee
-
Gut Dysbiosis may adversely impact treatment responses with TKIs in ABL-rearranged high-risk B-ALL
Page, E. (Speaker)
29 Oct 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Metabolic vulnerabilities of myeloid neoplasm and autoimmune disease.
Hiwase, D. (Speaker)
15 Oct 2024 → 17 Oct 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
New Directions in Leukaemia Research
Thomas, D. (Organiser)
4 Mar 2024 → 6 Mar 2024Activity: Participating in or organising an event › Organising a conference
-
MDS Recent Updates
Hiwase, D. (Invited speaker)
17 Nov 2024 → 18 Nov 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Tyrosine kinase inhibitor-responsive chronic myeloid leukaemia is associated with reduced OXPHOS capacity and mtDNA mutations likely contribute to this.
Pagani, I. (Speaker)
15 May 2024 → 17 May 2024Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
New Directions in Leukaemia Research
Pagani, I. (Member of programme committee)
4 Mar 2024 → 6 Mar 2024Activity: Participating in or organising an event › Participation in workshop, seminar, course
-
Australian CML Association, CMLa (External organisation)
Pagani, I. (Chair)
1 Mar 2024Activity: Membership › Membership of network
-
Clinical Spotlight Presentation - Chronic Myeloid Leukaemia: Next Challenges
Hughes, T. (Speaker)
4 Mar 2024 → 5 Mar 2024Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
New Directions in Leukaemia Research
White, D. (Participant)
4 Mar 2024 → 6 Mar 2024Activity: Participating in or organising an event › Organising a conference
-
New Directions in Leukaemia Research (NDLR)
Eadie, L. (Participant)
4 Mar 2024 → 6 Mar 2024Activity: Other
-
26th Annual ESH-iCMLF International Conference on CML – Biology and Therapy
Eadie, L. (Participant)
27 Sept 2024 → 29 Sept 2024Activity: Other
-
-
-
-
New Directions in Leukaemia Research (NDLR)
Eadie, L. (Speaker)
4 Mar 2024 → 6 Mar 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
The 5th Australian Cancer and Metabolism Meeting (ACMM 2024)
Thomas, D. (Organiser) & Butler, L. (Organiser)
15 Oct 2024 → 17 Oct 2024Activity: Participating in or organising an event › Organising a conference
-
When Frontline Therapy Fails
Yeung, D. (Invited speaker)
17 Oct 2024 → 18 Oct 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
CML Beyond Chronic Phase
Shanmuganathan, N. (Invited speaker)
17 Oct 2024 → 18 Oct 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Therapy-related myeloid neoplasm: when genetics collide with environment
Hiwase, D. (Invited speaker)
4 Mar 2024 → 6 Mar 2024Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
New Directions in Leukaemia Research
Thomas, D. (Participant)
4 Mar 2024 → 6 Mar 2024Activity: Participating in or organising an event › Organising a conference
-
Association of Italian Researchers in Australasia, ARIA (External organisation)
Pagani, I. (Chair)
1 Feb 2024Activity: Membership › Membership of board
-
ESH - iCMLf 26th Annual John Goldman Conference on Chronic Myeloid Leukemia
Hughes, T. (Organiser)
27 Sept 2024 → 29 Sept 2024Activity: Participating in or organising an event › Organising a conference
-
CML Opinion Leaders Training COLT 2024
Yeung, D. (Organiser) & Hughes, T. (Organiser)
17 Oct 2024 → 18 Oct 2024Activity: Participating in or organising an event › Organising a workshop, seminar, course
-
Scientific Exchange: The Disconnect Between Basic and Clinical Research
White, D. (Speaker)
2 Sept 2024Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Healthcare of the Future
White, D. (Keynote speaker)
5 Jul 2024Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
ALL-IMMUNE Study Update
White, D. (Keynote speaker)
13 Dec 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
ALL-IMMUNE Study Update
White, D. (Keynote speaker)
9 Sept 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
New Directions in Leukaemia Research (NDLR)
Eadie, L. (Participant)
4 Mar 2024 → 6 Mar 2024Activity: Other
-
Zero Childhood Cancer National Symposium
Eadie, L. (Participant)
8 May 2024 → 9 May 2024Activity: Other
-
Royal Australian and New Zealand College of Radiologists (External organisation)
Le, H. (Chair)
Jan 2024Activity: Membership › Membership of committee
-
New Directions in Leukaemia Research (NDLR)
Eadie, L. (Participant)
4 Mar 2024 → 6 Mar 2024Activity: Other
-
Mesenchymal stromal cells from patients with therapy-related myeloid neoplasms exhibit a unique metabolic phenotype with defective adipocyte differentiation.
Kutyna, M. (Speaker)
15 May 2024 → 17 May 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Ph+ ALL Management - 2024
Yeung, D. (Invited speaker)
17 Oct 2024 → 18 Oct 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
CMML Diagnostics and Therapy
Thomas, D. (Invited speaker)
17 Oct 2024 → 18 Oct 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Treatment Free Remission: MRD Studies.
Pagani, I. (Invited speaker)
17 Oct 2024 → 18 Oct 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
ESH - iCMLf 26th Annual John Goldman Conference on Chronic Myeloid Leukemia
Hughes, T. (Chair)
27 Sept 2024 → 29 Sept 2024Activity: Participating in or organising an event › Participation in conference
-
Transcriptomic analysis reveals the intricacies of Ph+ ALL: Examining gene expression patterns and deletions in relation to patient prognosis.
White, D. (Speaker)
27 Sept 2024 → 29 Sept 2024Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
New Directions in Leukaemia Research
White, D. (Organiser)
4 Mar 2024 → 6 Mar 2024Activity: Participating in or organising an event › Organising a conference
-
ALL-IMMUNE Study Update
White, D. (Keynote speaker)
24 Jun 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Ph+ and Ph-like ALL: New Insights
White, D. (Invited speaker)
17 Oct 2024 → 18 Oct 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
ALL-IMMUNE Study Update
White, D. (Keynote speaker)
10 Dec 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks